Numerous studies have demonstrated that inflammatory cytokines played an essential role in the development of NAFLD through the activation of various inflammatory pathways that interfere with insulin signaling (31, 32), such as IL-1β, IL-6, and IL-17. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatotic liver disease.